What does DOPHALINE do?

DOPHALINE is a farm in Lochristi. Private Limited, started on 28 December 1995, 2 establishments.

What is the address of DOPHALINE?

The registered office of DOPHALINE is located at Langelede 27, 9185 Lochristi.

Is DOPHALINE still active?

Yes. According to the CBE (30 October 2026) DOPHALINE is active, legal situation “Normale toestand”, started on 28 December 1995.

Is DOPHALINE registered on Peppol?

Yes, DOPHALINE is registered on the Peppol network with ID 0208:0456858815.

What is the enterprise number of DOPHALINE?

The enterprise number of DOPHALINE is BE0456858815.

When was DOPHALINE founded?

DOPHALINE was founded on 28 December 1995.

Who are the directors of DOPHALINE?

According to the 2026 annual accounts, the directors of DOPHALINE are: Catherina De Geeter, Wim De Waele.

Is DOPHALINE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 December 1995; 5 annual accounts filed, latest fiscal year 2026; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did DOPHALINE make in 2026?

DOPHALINE posted a profit after taxes of € 1,382,983 in financial year 2026.

What is the revenue of DOPHALINE?

As a small company, DOPHALINE is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 2,199,625.

How much does an employee at DOPHALINE earn?

The average wage cost per full-time employee at DOPHALINE was € 58,200 in 2026: staff costs of € 174,698 for 3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does DOPHALINE have?

According to the 2026 annual accounts, DOPHALINE has 3 full-time equivalents (FTE).

DOPHALINE (Private Limited) - Lochristi - BE0456858815

Dossier DOPHALINE, printed on 30 October 2026 from databakkes.be/en/0456858815/dophaline. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

DOPHALINE from Lochristi, company number BE0456858815, closed financial year 2026 with a result of € 1.4 million after tax. For that financial year DOPHALINE recorded a gross margin of € 2.2 million and equity of € 3.9 million. Compared with financial year 2025, the result moved from € 754,677 to € 1.4 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 6, 2026.

What it is worth Growing

€ 3.9 million

▲ 25% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1.4 million

▲ 83% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 573,745

▲ 93% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 604,800 paid out

44 % of the profit went to the shareholders, mostly to WICA (100 % of the shares). That is where the money ends up.

People and assets in 2026

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 174,698

▲ 5% vs 2025

€ 58,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 352,114

▼ 11% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1.1 million

▲ 74% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 55,370

▲ 19% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 997,750 Gross margin 2023: € 997,750 First fiscal year in the series	€ 754,047 Gross margin 2024: € 754,047 ▼ 24% vs 2023 (€ 997,750) Unfavourable step	€ 1,345,276 Gross margin 2025: € 1,345,276 ▲ 78% vs 2024 (€ 754,047) Favourable step	€ 2,199,625 Gross margin 2026: € 2,199,625 ▲ 64% vs 2025 (€ 1,345,276) Favourable step	▲ 64%
Profit after taxes	€ 471,588 Profit after taxes 2023: € 471,588 First fiscal year in the series	€ 360,392 Profit after taxes 2024: € 360,392 ▼ 24% vs 2023 (€ 471,588) Unfavourable step	€ 754,677 Profit after taxes 2025: € 754,677 ▲ 109% vs 2024 (€ 360,392) Favourable step	€ 1,382,983 Profit after taxes 2026: € 1,382,983 ▲ 83% vs 2025 (€ 754,677) Favourable step	▲ 83%
Equity	€ 2,236,954 Equity 2023: € 2,236,954 First fiscal year in the series	€ 2,597,346 Equity 2024: € 2,597,346 ▲ 16% vs 2023 (€ 2,236,954) Favourable step	€ 3,150,423 Equity 2025: € 3,150,423 ▲ 21% vs 2024 (€ 2,597,346) Favourable step	€ 3,928,607 Equity 2026: € 3,928,607 ▲ 25% vs 2025 (€ 3,150,423) Favourable step	▲ 25%
Total debts	€ 1,536,330 Total debts 2023: € 1,536,330 First fiscal year in the series	€ 1,593,695 Total debts 2024: € 1,593,695 ▲ 4% vs 2023 (€ 1,536,330) Unfavourable step	€ 1,490,787 Total debts 2025: € 1,490,787 ▼ 6% vs 2024 (€ 1,593,695) Favourable step	€ 2,360,091 Total debts 2026: € 2,360,091 ▲ 58% vs 2025 (€ 1,490,787) Unfavourable step	▲ 58%
Cash	€ 667,759 Cash 2023: € 667,759 First fiscal year in the series	€ 277,801 Cash 2024: € 277,801 ▼ 58% vs 2023 (€ 667,759) Unfavourable step	€ 297,811 Cash 2025: € 297,811 ▲ 7% vs 2024 (€ 277,801) Favourable step	€ 573,745 Cash 2026: € 573,745 ▲ 93% vs 2025 (€ 297,811) Favourable step	▲ 93%
Retained profit	€ 2,131,954 Retained profit 2023: € 2,131,954 First fiscal year in the series	€ 2,492,346 Retained profit 2024: € 2,492,346 ▲ 17% vs 2023 (€ 2,131,954) Favourable step	€ 3,045,423 Retained profit 2025: € 3,045,423 ▲ 22% vs 2024 (€ 2,492,346) Favourable step	€ 3,823,607 Retained profit 2026: € 3,823,607 ▲ 26% vs 2025 (€ 3,045,423) Favourable step	▲ 26%
Dividend	€ 201,600 Dividend 2023: € 201,600 First fiscal year in the series	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 201,600) Unchanged	€ 201,600 Dividend 2025: € 201,600 Unchanged (€ 0) Unchanged	€ 604,800 Dividend 2026: € 604,800 ▲ 200% vs 2025 (€ 201,600) Unchanged	▲ 200%
Balance sheet total	€ 3,773,283 Balance sheet total 2023: € 3,773,283 First fiscal year in the series	€ 4,191,041 Balance sheet total 2024: € 4,191,041 ▲ 11% vs 2023 (€ 3,773,283) Unchanged	€ 4,641,211 Balance sheet total 2025: € 4,641,211 ▲ 11% vs 2024 (€ 4,191,041) Unchanged	€ 6,288,697 Balance sheet total 2026: € 6,288,697 ▲ 35% vs 2025 (€ 4,641,211) Unchanged	▲ 35%
Employees (FTE)	3 Employees (FTE) 2023: 3 First fiscal year in the series	3 Employees (FTE) 2024: 3 Unchanged (3) Unchanged	3 Employees (FTE) 2025: 3 Unchanged (3) Unchanged	3 Employees (FTE) 2026: 3 Unchanged (3) Unchanged

Key figures of DOPHALINE, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to DOPHALINE?

What happened at DOPHALINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 6, 2026 New annual accounts for financial year 2026: profit of € 1.4 million (▲ 83% vs 2025). Source: NBB ↗
Feb 23, 2026 New establishment in Lochristi. KBO
Feb 7, 1996 New establishment in Lochristi. KBO
Dec 28, 1995 Start of the company according to the CBE. KBO

In short

From € 471,588 profit in 2023 to € 1.4 million profit in 2026.

Paid € 1 million in corporate taxes since 2023.

Best year ever: 2026, with € 1.4 million profit.

On average € 733,200 of value added per employee in 2026.

Original PDFs at the National Bank ↗

Management

WICA 99.5%

The stake of WICA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

DOPHALINE

Behind DOPHALINE are Catherina De Geeter and Wim De Waele. The shares are held by WICA (99.5%).

Directors

According to the 2026 annual accounts

Catherina De Geeter

Director

Also active at: WICA

Wim De Waele

Director

Also active at: WICA

Shareholders

WICA

99.5%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Langelede 27

9185 Lochristi

2.075.089.623

Groenstraat 43A

9185 Lochristi

Active since 7 February 1996

2.385.496.749

Eikstraat 24

9080 Lochristi

Active since 23 February 2026

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

WICA same network

€ 53,831 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0456.858.815

VAT number

BE 0456.858.815

Registered office

Langelede 27, 9185 Lochristi

Names & denominations

DOPHALINE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 December 1995

Peppol

Active · Active since 27 Nov 2025

Activities · NACE

Gemengd landbouwbedrijf

Gemengd bedrijf

Rundveehouderij

Fokken en houden van melkvee

Groothandel in levende dieren

Groothandel in levend vee

View on CBE Public ↗ Annual accounts (NBB) ↗

DOPHALINE

Financials

What happened to DOPHALINE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions